No One Really Plans to Have MS: Transition Readiness and Quality of Life in Pediatric Multiple Sclerosis
Background: Pediatric MS, defined as onset before the age of 18, is estimated to occur in over 8,000 children in the United States with...
Recently Diagnosed Early-Stage RRMS: Neda, ARR, Disability Progression, Serum Neurofilament and Safety: 1-Year Interim Data from the Ocrelizumab Phase IIIb ENSEMBLE Study
Background: Early treatment of multiple sclerosis (MS) and rapid onset of therapeutic effect provide long-term benefits on disease...
Association between Cognition and Social Role Participation Among Patients with Multiple Sclerosis
Background: Multiple sclerosis (MS), a relapsing and progressive demyelinating disease of the central nervous system, results in impaired...